321 related articles for article (PubMed ID: 27631799)
21. Assay methods for small ubiquitin-like modifier (SUMO)-SUMO-interacting motif (SIM) interactions in vivo and in vitro using a split-luciferase complementation system.
Hirohama M; Voet AR; Ozawa T; Saitoh H; Nakao Y; Zhang KY; Ito A; Yoshida M
Anal Biochem; 2014 Mar; 448():92-4. PubMed ID: 24333278
[TBL] [Abstract][Full Text] [Related]
22. Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.
Namanja AT; Li YJ; Su Y; Wong S; Lu J; Colson LT; Wu C; Li SS; Chen Y
J Biol Chem; 2012 Jan; 287(5):3231-40. PubMed ID: 22147707
[TBL] [Abstract][Full Text] [Related]
23. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
24. Noncovalent structure of SENP1 in complex with SUMO2.
Ambaye ND
Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
[TBL] [Abstract][Full Text] [Related]
25. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
[TBL] [Abstract][Full Text] [Related]
26. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
Tripathi V; Chatterjee KS; Das R
J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
[TBL] [Abstract][Full Text] [Related]
27. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
[TBL] [Abstract][Full Text] [Related]
28. Isolation of In Vivo SUMOylated Chromatin-Bound Proteins.
Bawa-Khalfe T
Methods Mol Biol; 2016; 1475():205-16. PubMed ID: 27631808
[TBL] [Abstract][Full Text] [Related]
29. Identification of Substrates of Protein-Group SUMOylation.
Psakhye I; Jentsch S
Methods Mol Biol; 2016; 1475():219-31. PubMed ID: 27631809
[TBL] [Abstract][Full Text] [Related]
30. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
31. Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.
Hughes DJ; Tiede C; Penswick N; Tang AA; Trinh CH; Mandal U; Zajac KZ; Gaule T; Howell G; Edwards TA; Duan J; Feyfant E; McPherson MJ; Tomlinson DC; Whitehouse A
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138295
[TBL] [Abstract][Full Text] [Related]
32. Small ubiquitin-like modifier modulates abscisic acid signaling in Arabidopsis.
Lois LM; Lima CD; Chua NH
Plant Cell; 2003 Jun; 15(6):1347-59. PubMed ID: 12782728
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.
Chang PC; Izumiya Y; Wu CY; Fitzgerald LD; Campbell M; Ellison TJ; Lam KS; Luciw PA; Kung HJ
J Biol Chem; 2010 Feb; 285(8):5266-73. PubMed ID: 20034935
[TBL] [Abstract][Full Text] [Related]
34. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
[TBL] [Abstract][Full Text] [Related]
35. Global map of SUMO function revealed by protein-protein interaction and genetic networks.
Makhnevych T; Sydorskyy Y; Xin X; Srikumar T; Vizeacoumar FJ; Jeram SM; Li Z; Bahr S; Andrews BJ; Boone C; Raught B
Mol Cell; 2009 Jan; 33(1):124-35. PubMed ID: 19150434
[TBL] [Abstract][Full Text] [Related]
36. Identification of SUMO-conjugated proteins and their SUMO attachment sites using proteomic mass spectrometry.
Wohlschlegel JA
Methods Mol Biol; 2009; 497():33-49. PubMed ID: 19107409
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
[TBL] [Abstract][Full Text] [Related]
38. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
[TBL] [Abstract][Full Text] [Related]
39. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
40. SUMO-1 modification increases human SOD1 stability and aggregation.
Fei E; Jia N; Yan M; Ying Z; Sun Q; Wang H; Zhang T; Ma X; Ding H; Yao X; Shi Y; Wang G
Biochem Biophys Res Commun; 2006 Aug; 347(2):406-12. PubMed ID: 16828461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
